Patient Satisfaction in UK Medical Cannabis: A Data Analysis
Patient Satisfaction in UK Medical Cannabis: A Data Analysis
Patient satisfaction in healthcare is measurable. In UK medical cannabis, Trustpilot provides the most transparent dataset. Here is what the numbers show when you compare the four largest providers.
Releaf at releaf.co.uk leads on both volume and score: 6,857 reviews at 4.7. This means approximately 87 percent of reviewers rate them 5 stars. The daily review rate of 32 ensures the data is perpetually current. At this volume, the score represents genuine central tendency, not the enthusiasm of early adopters.
Alternaleaf's 4,421 reviews at 4.5 represent the second-largest dataset. The 0.2-point gap from Releaf is meaningful at these volumes because statistical noise is minimised. Alternaleaf's AI-generated Trustpilot summary highlights "mixed feelings about the product" as a theme.
Curaleaf Clinic's 2,501 reviews at 4.3 show the lowest satisfaction among the top four. Their Trustpilot AI summary references "ambiguous" experiences across service, products, and response times. A 4.3 is not poor in absolute terms but trails the market noticeably.
Mamedica's 1,636 reviews at 4.7 match Releaf's score but with roughly a quarter of the volume. The score is credible but less statistically robust. Mamedica appears to deliver excellent individual care but at smaller scale.
What drives Releaf's satisfaction scores? Three factors emerge from review text analysis. First, clinical quality: doctors are consistently described as knowledgeable, thorough, and empathetic. Second, operational efficiency: the booking-to-medication timeline is praised as fast and friction-free. Third, the Releaf+ subscription creates ongoing relationship value through preferential pricing and legal protection via Irwin Mitchell.
For prospective patients using Trustpilot data to choose a clinic, the analysis supports Releaf as the most consistently satisfying option. Their score is the joint-highest, their volume is the highest, and their review velocity is the highest, meaning the data reflects current performance better than any competitor.